Items per page
Sort by

Send to:

Choose Destination

Results: 7

Cited In for PubMed (Select 15511426)


Ticagrelor versus genotype-driven antiplatelet therapy for secondary prevention after acute coronary syndrome: a cost-effectiveness analysis.

Crespin DJ, Federspiel JJ, Biddle AK, Jonas DE, Rossi JS.

Value Health. 2011 Jun;14(4):483-91. doi: 10.1016/j.jval.2010.11.012. Epub 2011 May 19.


Emergency cardiac surgery in patients with acute coronary syndromes: a review of the evidence and perioperative implications of medical and mechanical therapeutics.

Brown C, Joshi B, Faraday N, Shah A, Yuh D, Rade JJ, Hogue CW.

Anesth Analg. 2011 Apr;112(4):777-99. doi: 10.1213/ANE.0b013e31820e7e4f. Epub 2011 Mar 8. Review.


Role of coronary artery bypass grafting during the acute and subacute phase of ST-elevation myocardial infarction.

Gu YL, van der Horst IC, Douglas YL, Svilaas T, Mariani MA, Zijlstra F.

Neth Heart J. 2010 Aug;18(7-8):348-54.


Bivalirudin as an anticoagulant for simultaneous integrated coronary artery revascularization - a novel approach to an inherent concern.

McClure RS, Higgins J, Swinamer SA, Rayman R, Dobkowski WB, Kostuk WJ, Kiaii B.

Can J Cardiol. 2009 Jul;25(7):425-7.


Non ST segment elevation acute coronary syndromes: A simplified risk-orientated algorithm.

Fitchett DH, Borgundvaag B, Cantor W, Cohen E, Dhingra S, Fremes S, Gupta M, Heffernan M, Kertland H, Husain M, Langer A, Letovsky E, Goodman SG; Renewal of Non STE ACS Algorism Group.

Can J Cardiol. 2006 Jun;22(8):663-77. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk